-Reuters
FDA Briefing Document For Amylyx Pharmaceuticals’ AMX0035 (Full document)
https://www.fda.gov/media/161378/download
Related Posts
B of A Securities Downgrades California Resources to Underperform, Announces $49 Price Target
B of A Securities analyst Doug Leggate downgrades California Resources (NYSE:CRC) from Buy to Underperform and announces $49 price target.
Charlotte’s Web Stock Slightly Up On Secured $56.8M Investment From BAT
Charlotte's Web Holdings, Inc. (OTCQX: CWBHF) (TSX:CWEB) announced a $56.8 million investment from a subsidiary of BAT (NYSE: BTI) (LSE:BATS), which provides the company with incremental capital to fund growth initiati
AudioEye Q4 EPS $(0.17) Beats $(0.22) Estimate, Sales $7.74M Miss $7.75M Estimate
AudioEye (NASDAQ:AEYE) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.22) by 22.73 percent. This is a 6.25 percent decrease over losses of $(0.16) per share from the same